Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Agrawal

Showing results (561-570 of 562) with videos related to

Pageof 57
Sort By:
You have reached the last page of results.This site can display upto 562 results.
The Lancet. Global Health|August 23, 2020
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trialVijay Patil, Vanita Noronha, Sachin Babanrao Dhumal, et al.
Nature Communications|May 19, 2026
High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunitiesLucia Chmelova, Helen R Davies, Andrea Degasperi, et al.
Pageof 57

Showing results (561-570 of 562) with videos related to

Sort By:
Pageof 57
You have reached the last page of results.This site can display upto 562 results.
The Lancet. Global Health|August 23, 2020
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trialVijay Patil, Vanita Noronha, Sachin Babanrao Dhumal, et al.
Nature Communications|May 19, 2026
High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunitiesLucia Chmelova, Helen R Davies, Andrea Degasperi, et al.
Pageof 57